H.R. 1117: Responsibility in Drug Advertising Act of 2025

H.R. 1117 is a federal bill in the 119th Congress. Currently, drug companies can advertise new prescription drugs directly to consumers as soon as the Food and Drug Administration (FDA) approves them. This bill would change that by preventing drug companies from advertising new drugs directly to consumers… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.